vTv Therapeutics (VTVT) Receivables - Net (2015 - 2024)

vTv Therapeutics has disclosed Receivables - Net across 10 years of filings, most recently posting $62000.0 for Q4 2024.

• Receivables - Net for Q4 2024 came in at $62000.0, down 39.22% year-over-year; the trailing twelve-month figure through Dec 2024 was $62000.0 (down 39.22% YoY), and the FY2024 annual result was $62000.0, down 39.22% from the prior year.
• Receivables - Net came in at $62000.0 for Q4 2024 at vTv Therapeutics, down from $242000.0 in the prior quarter.
• In the past five years, Receivables - Net ranged from a high of $12.5 million in Q3 2022 to a low of $2000.0 in Q1 2021.
• The 5-year median for Receivables - Net is $102000.0 (2023), against an average of $1.0 million.
• Peak annual rise in Receivables - Net reached 6528.57% in 2021, while the deepest fall reached 63.92% in 2021.
• vTv Therapeutics' Receivables - Net stood at $158000.0 in 2020, then tumbled by 63.92% to $57000.0 in 2021, then surged by 203.51% to $173000.0 in 2022, then plunged by 41.04% to $102000.0 in 2023, then sank by 39.22% to $62000.0 in 2024.
• The last three Receivables - Net figures came in at $62000.0 (Q4 2024), $242000.0 (Q3 2024), and $306000.0 (Q2 2024), per Business Quant data.